The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
The discovery of vaccine antigens through whole genome sequencing (WGS) contrasts with the classical hypothesis-driven laboratory-based analysis of microbes to identify components to elicit protective immunity. This radical change in scientific direction and action in vaccine research is captured in...
Main Authors: | Vega Masignani, Mariagrazia Pizza, E. Richard Moxon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00751/full |
Similar Items
-
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland
by: Robert M. Mulhall, et al.
Published: (2018-08-01) -
Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab
by: Deirdre Nolfi-Donegan, et al.
Published: (2018-08-01) -
Caracterización fenotípica y genotípica de aislamientos de Neisseria meningitidis, serogrupo B, procedentes de Cartagena, Colombia, 2012-2014
by: Jaime Moreno, et al.
Published: (2015-03-01) -
Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence
by: Sara Boccalini, et al.
Published: (2020-10-01) -
Genomic Analysis of the Evolution and Global Spread of Hyper-invasive Meningococcal Lineage 5
by: Odile B. Harrison, et al.
Published: (2015-03-01)